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Abstract 27 
Objectives: To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (TresidentÔ (Shütz Dental 28 
Group GmbH, Germany) compared to an irreversible hydrocolloid (OrthoprintÔ, Zhermack SpA, Italy) for ocular 29 
impression taking. 30 
Methods: Twenty subjects were recruited (13 female and 7 male), mean age 31.1±4.6 years [SD] (range 25.8 to 31 
39.7). Subjects attended for 2 sessions, each of 1 hr duration, on 2 separate days. Each session was scheduled at 32 
the same time on each day. At each visit the subject underwent an ocular impression procedure, using either 33 
Tresident or Orthoprint, in random order and to one eye only. Investigator 2 was blind to this assignment. Two 34 
experienced practitioners carried out the study, Investigator 1 performed the ocular impression procedures and 35 
Investigator 2 observed and assessed the clinical signs: logMAR visual acuity (VA), ocular surface staining, tear 36 
break-up time (TBUT), and ocular hyperaemia. 37 
Results: VA was unaffected by either material; TBUT was marginally disrupted by both materials, but was not 38 
clinically significant according to published criteria; ocular redness increased with both materials; corneal staining 39 
was significantly greater after Orthoprint impression. Less redness and clinically insignificant staining following 40 
impression-taking, with fewer clinical complications, was found following use of Tresident. 41 
Conclusions: Tresident offers a quicker, more effective and clinically viable method of obtaining ocular impression 42 
topography compared to the traditional Orthoprint; and Orthoprint causes significantly more superficial 43 
punctuate staining of the corneal epithelium than Tresident. 44 
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The purpose of taking an impression of any surface is to mould the negative dimensions of the structure and 48 
make a model of the 'positive' physical properties, which then provides an accurate representation of the shape, 49 
parameters and spatial relationships. Ocular impression taking is used in scleral contact lens fitting and ocular 50 
prosthesis manufacturing. In both situations, an accurate representation of the existing ocular surface is critical 51 
for success1. For example, in scleral contact lens fitting, the eye impression produced enables the manufacture of 52 
the lens to match with the patient’s ocular surface topography. Alternative optical methods are now available, 53 
and used, for scleral lens fitting, but ocular impression-taking remains a vital component of the clinician’s toolkit, 54 
and will also provide information over a larger scleral area. Ocular impression taking is also relatively inexpensive, 55 
can be used outside of the clinical office room, and are reproducible1,2. To our knowledge, no studies have been 56 
published that report on the effect of impression taking on the ocular surface, in a comparison between two 57 
established impression materials. 58 
 59 
The characteristics of the 'ideal' ocular impression material include: minimal deleterious effects on the anterior 60 
ocular surface (AOS) or exposed ocular adnexa by the material; no lasting discomfort after the procedure (topical 61 
anaesthetic blocks the sensory corneal nerves during the procedure); high accuracy - the acceptable magnitude of 62 
error in impression taking is determined by its desired application, e.g. gas permeable contact lens manufacturing 63 
requires high accuracy (±0.05mm) to match the manufacturing tolerances of BS/EN/ISO/18369-2:20123; excellent 64 
dimensional stability to ensure the material is not deformed by plaster pouring, or degraded by environmental 65 
conditions or physical manipulation; good flow characteristics and reasonable in-eye working time to allow 66 
sufficient time for the material to be applied to the impression tray and inserted without setting; rapid curing or 67 
setting time to reduce the amount of time required to maintain the material against the eye, thereby reducing 68 
artefacts incurred by random eye movements; and, excellent compatibility with gypsum dental stone (some 69 
impression materials are known to cause chemical degradation of the gypsum cast surface). 70 
 71 
Cold, irreversible hydrocolloids or alginates (e.g. OrthoprintÔ, Zhermack SpA, Italy), which have been used for 72 
ocular impressions since the introduction of Ophthalmic Moldite4, exhibit poor dimensional stability and poor tear 73 
 4 
strengths, leading to inaccurate casts and the need for multiple impression-taking procedures5,6. The impressions 74 
formed are affected by: (1) the level of airflow around the impression, which causes evaporation of water from 75 
the gel, resulting in shrinkage; (2) by water, which causes the gel to expand by imbibition and absorption; (3) by 76 
high relative humidity, which induces syneresis and shrinkage; and (4) by in-organic salts, which affect the gel and 77 
cause physical changes that are dependent on their osmotic potential7. 78 
 79 
Orthoprint (Zhermack SpA, Italy) is a yellow, dust-free, alginate, irreversible, hydrocolloid impression material, 80 
which conforms to BS/EN/ISO/21563:20138, with origins in dental practice (Table 1). It provides good surface 81 
detail9, is easy to use and mix, is cheap and has a long shelf-life, numbered in years7. The setting time can be 82 
controlled with water temperature and, as a gel, it is non-toxic and non-irritant10. However, it has relatively poor 83 
dimensional stability, compared with elastomers, and a low tear energy11. It is incompatible with Type 1 or 2 84 
gypsum plaster12,13, reacts to humidity, and has a very short on-eye setting time (45 secs). The mixing process is 85 
messy and dependent on operator handling. Automated mechanical mixing has been shown to increase speed 86 
and quality of alginate sol, eliminating casting imperfections14. For these reasons, the use of alginate for ocular 87 
impression-taking has been superseded by silicone rubber-based materials. 88 
 89 
Polyvinylsiloxane polymers appear to allow reproduction of the greatest detail of all dental impression 90 
materials15. Indeed, the material provides sufficient detail to identify individuals by fingerprint analysis16. This 91 
level of accuracy is defined by BS/EN/ISO/4823:201517, which requires that all Type 3, light-bodied, elastomeric 92 
materials be able to reproduce a line 0.02mm in width. In addition, these materials have been found to have very 93 
low shrinkage (0.05-0.1%), during the polymerising process18, and are well-matched to the setting expansion of 94 
Type 4 gypsum plaster, which is used to cast the impression19. 95 
 96 
TresidentÔ (Shütz Dental Group GmbH, Germany) is a low viscosity, addition-polymerising, polyvinylsiloxane 97 
precision impression material with hydrophilic properties, which conforms to BS/EN/ISO/4823:201517 (Table 1). It 98 
is supplied in an auto-mix dual-cartridge, which requires a dispensing gun to automatically mix and advance equal 99 
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quantities of each siloxane-based component through a purpose-designed mixing cannula (Injector DS 50, Dreve 100 
Otoplastik GmbH, Germany). Tresident provides a working time of 1 min 15 secs, with a setting time of 2 mins 45 101 
secs, giving a total setting time of 4 mins. During the setting time, the impression tray and material must be held 102 
against the ocular surface under gentle pressure. Plaster casts can be produced from the moulds, and can be 103 
poured from 1 hr to 14 days after the procedure. Further casts can be produced from each Impression, which are 104 
as accurate as the original, for up to 7 days20, but to do so the impression material must be kept in a dry place at 105 
18-25°C. Re-heating the impression to 37°C before pouring the plaster has been shown to improve accuracy of 106 
casting. However, it is doubtful if this is clinically significant21. 107 
 108 
The two components of the material are a polymethyl-hydrogen-siloxane copolymer of moderately low molecular 109 
mass, which contains silane terminal groups, and an accelerator material of a similar molecular weight, which 110 
contains vinyl-terminated polydimethyl siloxane. When mixed, the silane and vinyl groups react, catalysed by 111 
chloroplatinic acid (a homogenous, metal complex catalyst). The cross-linking that occurs during the 112 
polymerisation process causes minimal dimensional change and there are no by-products22. Both components 113 
contain fillers, amorphous silica and a low molecular weight retarder to delay the onset of polymerisation. 114 
Additionally, the base component has an emulsifying surfactant that improves the wettability of the impression. 115 
Colouring agents are added to distinguish between the two pastes and aid the evaluation of mixing process. 116 
 117 
Polyvinylsiloxane materials have been found to have good long-term dimensional stability (up to 2 weeks), are not 118 
susceptible to changes in humidity, and do not undergo further chemical reactions or release by-products15. Tests 119 
carried out on intact rabbit skin concluded that the primary skin irritation of polyvinylsiloxane can be considered 120 
negligible23. For these reasons, it is considered a superior alternative to the irreversible hydrocolloids. Sydiskis and 121 
Gerhardt (1993)24 also showed that while both polyvinylsiloxane and irreversible hydrocolloid materials have a 122 
cytotoxic effect on cell culture, the risk of producing an adverse reaction is low. However, the effects of the 123 
material on the tear film and adnexa, although considered clinically acceptable, have not previously been 124 
reported.  125 
 6 
This study used a single-blind, randomised control trial to assess the efficacy and effect on clinical signs of a 126 
polyvinylsiloxane (Tresident) compared to an irreversible hydrocolloid (Orthoprint) for ocular impression taking. 127 
The hypotheses proposed are that: (1) Tresident offers a quicker, more effective and clinically viable method of 128 
obtaining ocular impression topography compared to the traditional Orthoprint; and (2) Orthoprint causes 129 
significantly more superficial punctuate staining of the corneal epithelium than Tresident. 130 
 131 
Materials and Methods 132 
Twenty subjects were included in the study, (13 female and 7 male), mean age was 31.1±4.6 years [SD] (range 133 
25.8-39.7). Volunteers were recruited from staff and students of Cardiff University, and subjects were excluded if 134 
they were pregnant or breastfeeding; had any ocular or systemic condition known to affect the structure or 135 
characteristics of the AOS; were taking any medication known to affect the ocular surface; had worn rigid contact 136 
lenses in the preceding 6 weeks or soft contact lenses in the preceding 2 weeks. Ethical approval was sought and 137 
granted in accordance with the Tenets of the Declaration of Helsinki (2004) from the Cardiff School of Optometry 138 
and Vision Sciences Human Research Ethics Committee. 139 
 140 
Subjects attended for 2 sessions, each of 1 hr duration, on 2 separate days. Each session was scheduled at the 141 
same time on each day. Two experienced practitioners carried out the study: one performed the ocular 142 
impression procedures (Investigator 1), and the other observed and assessed the clinical signs (Investigator 2). 143 
The practitioners carried out their investigations in separate rooms without any knowledge of the other’s results. 144 
Each subject was randomly assigned to receive an ocular impression in one eye, using one of the two impression 145 
material, by a study administrator. Investigator 2 was blind to this assignment. 146 
 147 
Session 1 148 
The subject arrived and was assessed by Investigator 2 for suitability and baseline clinical assessment 149 
measurements. Both eyes were assessed, but the data analysed only for the eye assigned for treatment. 150 
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1. Best-corrected LogMAR distance acuity (Sussex Vision International Ltd, West Sussex, UK) at 3m direct viewing. 151 
Visual acuity was obtained by assigning 0.02 LogMAR units to each letter. 152 
2. Instillation of fluorescein, using Fluoret strips (Chauvin, France) (each strip impregnated with approximately 153 
1mg of fluorescein sodium BP) moistened with 0.9% physiological saline, to assess invasive tear break-up time. 154 
The subject was asked to blink and then hold their eye open as long as possible. The measurement was taken in 155 
seconds between the blink and the first appearance of a discontinuity in tear film coverage. Three values were 156 
recorded for each eye and the median used for comparison. 157 
3. Tear break-up time using Tearscope Plus™ (Keeler Ltd, Windsor, UK), with fine grid insert. The measurement 158 
was taken in seconds between the blink and the first appearance of a discontinuity in tear film coverage. Three 159 
values were recorded for each eye and the median used for comparison. 160 
4. Assessment of ocular integrity using CCLRU grading scales (Brian Holden Vision Institute (BHVI)), interpolated to 161 
0.1 unit increments25: bulbar redness; limbal redness; lid redness; lid roughness; type, extent and depth of corneal 162 
staining with fluorescein. 163 
 164 
Ocular impression was then performed in a separate room, where Investigator 1 carried out an impression 165 
procedure to one ocular surface (randomly-assigned) using one of the two materials. After impression taking, and 166 
saline wash-out to remove excess material, the subject returned to the room of Investigator 2 who repeated the 167 
clinical tests as above. 168 
 169 
Session 2 170 
When the subject arrived, Investigator 2 repeated the clinical tests carried out the day before, followed by 171 
Investigator 1 taking an ocular impression with the alternative material to a randomly-assigned eye. Investigator 2 172 
repeated the clinical tests following a saline wash-out, post-impression procedure. 173 
 174 
Ocular impression procedure 175 
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Each subject was positioned sitting upright and facing forward. A distant target was provided to align the visual 176 
axes, using the contralateral eye for fixation. The ocular surfaces of both eyes were anaesthetised with 0.5% 177 
Proxymetacaine HCL Minims eye drops (Chauvin, Kingston-upon-Thames, UK), and the procedure carefully 178 
explained to the subject. An impression tray was chosen from the set of 3 sizes, of maximum internal shell 179 
diameter 23, 24 or 25mm (Cantor and Nissel Ltd, Brackley, UK). These trays are moulded from acrylic with hollow 180 
stems, 32mm in length, marked with red circular indentations providing an anatomical registration at the 12 181 
o'clock position (in relation to the cornea). The tray was selected by presenting the 3 sizes to the closed eye and 182 
choosing the largest in relation to the aperture and the global contour. Impression material was dispensed onto 183 
the internal surface of the shell covering the entire surface with 1.5-2.5mm26 of either Tresident or Orthoprint 184 
(Figure 1). 185 
 186 
The subject was instructed to 'look down' whilst remaining in the head upright position. The tray was inserted 187 
quickly under the top eyelid, and the subject was asked to 'look up' in order for the lower lid to be freed and the 188 
shell held between both eyelids. The tray was carefully positioned to locate the cornea at the centre of the shell; 189 
the investigator supported the stem and ensured that the subject maintained composure and optimal fixation 190 
(Figure 2). 191 
 192 
After setting of the material, the tray and impression was removed by freeing the lashes of the upper lid and 193 
removing the material from the eye surface in one piece. Any material remnants were collected and the fornices 194 
irrigated with 0.9% buffered saline. 195 
 196 
Statistical analysis 197 
All data was collated with Excel 2007 (Microsoft, WA, US), and analysed within SPSS v13 (IBM, NY, US). The data 198 
distribution was evaluated for normality using the Kolmogorov-Smirnov statistical test. Comparisons were made 199 
of clinical signs assessed before and after each impression procedure, and paired t-tests used to determine 200 
statistical significance at the 95% level. 201 
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 202 
Results 203 
A summary of the results is shown in Table 2. LogMAR acuity was found to be slightly reduced by 0.5 letters, on 204 
average, following impression using either material, but this was not statistically significant. 205 
 206 
TBUT was found to be reduced following impression-taking with both materials, but was not clinically significant. 207 
Mean TBUT was 7.16±1.40 secs pre- and 6.68±1.27 secs post-Tresident impression, with a difference of -208 
0.87±2.61 secs, which was not statistically significant (p=0.383). Mean TBUT was 7.42±1.55 secs pre- and 209 
6.61±1.33 secs post-Orthoprint impression, giving a larger difference of -1.28±2.03 secs, but which did not reach 210 
statistical significance (p=0.094). 211 
 212 
Ocular redness was found to increase following impression taking, with both impression materials. Bulbar redness 213 
increased following impression-taking with Tresident by +0.64±0.58 units (p<0.001), with a substantially greater 214 
change in redness observed following the use of Orthoprint +1.12±0.42 units (p<0.001). A statistical difference 215 
was found between the numerical values assigned to bulbar redness after Orthoprint compared to Tresident 216 
(p=0.0231). Similarly, limbal redness increased following impression-taking, +0.70±0.31 units (p<0.005) after 217 
Tresident use and +1.05±0.28 units (p<0.005) after Orthoprint. However, the mean difference between changes in 218 
limbal redness when comparing the two materials was not statistically significant (p=0.072). There was a small 219 
change in lid redness recorded after impression-taking. For Tresident this was 0.17 ±0.32units, which was 220 
statistically significant (p<0.05). However, the change was smaller after Orthoprint use (0.07 ±0.35 units) and was 221 
not statistically significant (p=0.487). 222 
 223 
The clinical grading of lid roughness was found to increase following impression-taking with Tresident (0.03 ±0.25 224 
CCLRU units), but this was not statistically significant (p=0.459). Orthoprint had no detectable effect on lid 225 
roughness. 226 
 227 
 10 
Corneal staining with fluorescein was recorded following impression-taking with both materials. Staining type was 228 
micro-punctate and superficial after Orthoprint; 0.13 ±0.34 grade units (p=0.341), but tended to be macro-229 
punctate after Tresident; 0.53 ±0.41 grade units (p=0.167). However, these changes were not statistically 230 
significant. 231 
 232 
The extent of staining was found to increase substantially after Orthoprint impression to 2.33 ±0.46 grade units 233 
(p<0.001). These measurements indicate that, on average, 22% of the corneal surface (range 15-45%) was 234 
covered by staining. The recorded increase in extent of staining after Tresident was small (0.49 ±0.65 grade units), 235 
was not statistically significant (p=0.209) and the surface area stained was, on average, only 10% (range 1-22%). 236 
Changes in the depth of staining were found to be small (0.31±0.40 grade units after Orthoprint, 0.37±0.47 grade 237 
units after Tresident), which were statistically significant for Orthoprint, p<0.05, but not for Tresident (p=0.219). 238 
 239 
Clinical summary 240 
Visual acuity was unaffected by either material (clinically significant criterion Test-retest ±>2.4 letters)27. TBUT 241 
was marginally disrupted by both materials, but was not clinically significant according to published criteria)28. 242 
Bulbar redness increased with both materials. Orthoprint induced a clinically significant hyperaemic response in 243 
over half of the cohort, i.e. >2.6 CCLRU grade units29,30, while Tresident was associated with increased bulbar 244 
redness within clinically acceptable limits. Both materials increased limbal redness, but this was within clinically 245 
acceptable limits (<2.4 CCLRU grade units30). Corneal staining was significantly greater after Orthoprint impression 246 
(clinically significant criterion >0.5 grade units)31. Orthoprint produced micro-punctate staining (type) over 15-247 
45% (extent) of the cornea, fluorescein penetrated the superficial epithelium. Tresident produced macro-248 
punctate staining (type) over 1-22% (extent) of the cornea, fluorescein penetrated the superficial epithelium. 249 
 250 
Discussion 251 
For the first time using clinical grading scales, the effects of Orthoprint and Tresident have been evaluated to 252 
determine the ocular surface disruption following ocular impression procedures, providing evidence to allow 253 
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practitioners to make an informed choice when deciding which material to use. The results from this study 254 
support the use of Tresident as the clinically safer impression material. It also requires less preparation time than 255 
Orthoprint. The use of Orthoprint was found to be associated with clinically significant (although superficial), 256 
micro-punctate staining of the corneal epithelium, leading to an increased bulbar hyperaemia response. In 257 
contrast, following the use of Tresident, ocular signs were within normal limits, with minimal corneal staining.  258 
 259 
After the use of Orthoprint, 7 subjects reported a foreign body sensation accompanied by a slightly red eye, which 260 
persisted for up to 24 hrs after the procedure. These subjects were monitored carefully, provided with ocular 261 
lubricants and all symptoms resolved spontaneously. Inflammatory signs were not observed on the tarsal 262 
conjunctiva or the dermis of the lids, although both areas were also in contact with Orthoprint during the 263 
procedure. This, coupled with the hyperaemia response, suggests that there may be some toxicity response from 264 
the AOS. This could be due to: poor mixing of the alginate resulting in one or a combination of the chemical 265 
constituents causing damage to epithelial cell integrity. In particular, potassium fluorotitanate (chemical modifier) 266 
is listed as a hazardous component on the Orthoprint data safety sheet. Between 1-3% of the impression mix is 267 
made up of this chemical, and, if in contact with eyes, it advises to wash immediately with water for at least 10 268 
mins. This effect might be prolonged if a chemical residue was left on the AOS after the gel was formed, which 269 
was not removed by irrigation. 270 
 271 
It is commonly accepted that fluorescein staining of the cornea represents compromised epithelial integrity32. A 272 
red eye, accompanied by corneal staining, is intuitively taken as an unhealthy ocular situation and good practice 273 
advocates monitoring for signs of deterioration and treatment if necessary. In this study, a clinically significant 274 
increase in staining was observed after Orthoprint, but not Tresident (Dundas et al.,200131 suggests that a score 275 
of >0.5 should be considered unusual). Damage to corneal integrity caused by one, or a multitude of factors, 276 
during ocular impression-taking requires careful monitoring and consideration given that any denudation of 277 
epithelium increases the risk of infection33. A number of factors may have contributed to the superficial staining 278 
observed on the cornea. 279 
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 280 
The use of anaesthetic prior to ocular impression-taking may have contributed to the corneal staining – 0.5% 281 
Proxymetacaine HCl has been associated with increased corneal permeability to fluorescein31. However, this was 282 
applied equally for both impression methods, so it may be assumed that the differences in staining observed 283 
between the methods is a true difference. 284 
 285 
The mechanism for observing corneal staining is typically to use surface fluorescein pooling or ingress around 286 
epithelial cells32. However, surface toxicity cannot be adequately explained in this manner. If Orthoprint does 287 
indeed cause a chemical interaction with tear mucins or membranes of the corneal and conjunctival epithelial 288 
cells, then fluorescein may be staining the affected cell complexes. Thus, the increased sensitivity reported by 289 
subjects after Orthoprint may be a result of the 'toxic' interaction that remains until the surface cells are sloughed 290 
off. The initial increased cell permeability by proxymetacaine anaesthesia may encourage the acute inflammatory 291 
response and increase subsequent corneal staining observed. 292 
 293 
This effect may be emphasised by increased permeability of the cornea. Physical contact between the ocular 294 
surface and the setting alginate medium may cause the removal of multiple epithelial cells, allowing chemical 295 
contamination of the deeper layers of the epithelium. In addition, anaesthetic instillation can cause reduced 296 
corneal sensitivity, reduced blink frequency and can precipitate abnormal drying of the AOS35, encouraging 297 
adherence of the impression material to the epithelium. Toxic interactions between anaesthetic and corneal 298 
epithelial cells have been found to cause loss or damage to surface microvilli and deposition onto the cell 299 
membranes36. 300 
 301 
Average bulbar redness using CCLRU scales in the normal population is reported to be 1.93 units, with scores of 302 
2.6 units considered abnormal29. Eleven subjects had scores greater than this following the use of Orthoprint, 303 
with an average score of 3.14±0.37 grade units (range 2.7-3.8). This constitutes an abnormal level of hyperaemia 304 
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in over half the study cohort. In contrast, after using Tresident, only six subjects had scores above normal, with an 305 
average of 3.31±0.41 units (range 2.8 - 3.8). 306 
 307 
The irritation of ocular tissues by irreversible hydrocolloids has been studied on white, adult, New Zealand rabbit 308 
eyes37 and clinical observations in human eyes found a range of responses to the material, ranging from slight 309 
dehydration and irritation of the tissues to transient corneal abrasions6. Ocularists described capillary dilation, 310 
tissue oedema and prolific tearing. The study concluded that the impression material, similar in formulation to 311 
Orthoprint, elicited a significant, acute, inflammatory response in the rabbit conjunctiva on histological 312 
examination. The authors attributed the tissue insult to the granular alginate material rubbing against the corneal 313 
and conjunctival tissue interface, concurrent with blinking and eye movement. Additionally, they speculated, as in 314 
this study, that the chemical setting aids (bimetallic fluorides) may have had a toxic effect on the ocular tissues. 315 
The effects of the inflammatory response lasted 24-72 hours, leaving no permanent tissue damage37. 316 
 317 
Conclusion 318 
The use of Orthoprint during ocular impression-taking caused an abnormal hyperaemic response to the bulbar 319 
conjunctiva, accompanied by significant superficial corneal staining. This may be attributed to a toxic reaction 320 
between the material and the eye surface, exacerbated by mechanical abrasion caused by eyelid movement and 321 
granular material apposition. However, further investigation would be necessary to establish the exact nature of 322 
this interaction. 323 
 324 
Tresident was found to be the impression material of choice. This study observed less redness and clinically 325 
insignificant staining following impression-taking with fewer clinical complications. To manage any clinical 326 
complications from using Tresident, the following advice is given: provide lubricating drops post-impression; 327 
review the ocular surface integrity 24 hrs later; exclude dry eye patients and those with a comprised ocular 328 
surface, where possible; and, consider prophylactic treatment for patients with damaged or impaired ocular 329 
surface function. 330 
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 331 
These findings, combined with favourable handling and excellent physical properties, makes Tresident a superior 332 
material for taking ocular impressions. 333 
 334 
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Titles and legends to figures 416 
Table 1: Properties and characteristics of Orthoprint and Tresident. 417 
 Tresident Orthoprint 
Material type Silicone elastomer Alginate 
Reaction type Addition polymerisation Irreversible hydrocolloid 
Components 
Base paste: silicone polymer dispersion 
and reactive species, filler and 
surfactant to increase hydrophilic 
properties. Catalyst paste: silicone 
polymer dispersion and reactive 
species, catalyst, hydrogen scavenging 
agent, filler and pigments20. 
Soluble alginate reacts with calcium sulphate to 
produce insoluble calcium alginate gel, 
potassium fluotitanate to counteract interaction 
with gypsum setting, filler, retarder, pH modifier 
and glycol to reduce dust35. 
Smell None Vanilla odour and flavour 
Detail reproduction 
Reproduce lines <0.020mm 
Unknown effect of pH 
Reproduce lines <0.75mm. Improved in 
alkaline pH36 
Linear dimensional change <1.5% Variable with temperature and humidity 
Elastic recovery >99% 97.3% 
Deformation 1.3-5.6% 11% 
Tear strength High 1640-5260g/cm Low 380-700g/cm 
Clinical history First used Britain 1977: Ann Arnold-Silk4 First used America 1943: Theodore Obrig37 
Mixing technique 
Dual chamber cartridge using proprietary 
mixing canula and dispensing gun 
By hand using rubber bowl and metal spatula. 
De-ionised water added to powder 
Quantities Quantities of each paste predetermined by 
means of cartridge and dispensing system 
9g powder to 18ml water 
Working time 1 min 15 secs 1 min 5 secs 
On-eye time 2 mins 45 secs 45 secs 
Setting time 4 mins 1 min 50 secs 
Gypsum die pouring 
After 1 hr, up to 14 days with no special 
conditions 
Immediately or up to 48 hrs later if stored in 
hermetically sealed bag at 23°C 
Number of casts Up to 7 1 
Environmental 
effects 
0.2-1% shrinkage after 24 hrs. Higher temp 
reduces setting time, unaffected by humidity 
Cold water retards setting time, shrinks up to 
1.28% after 24 hrs if not stored at high 
humidity38 
 418 
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Table 2: Statistical comparisons of clinical outcomes between Tresident and Orthoprint. 420 
Clinical Outcome Mean differences in measurements 
pre- and post-impression 
procedure (mean±SD) 
Statistical significance 
 Tresident Orthoprint Tresident pre- vs post- 
Orthoprint 
pre- vs post- 
Tresident vs 
Orthoprint 
LogMAR acuity 
(Log Units) -0.01±0.13 -0.01±0.21 p=0.414 p=0.082 p=0.593 
Phenol red test 
(mm) +5.06±6.22 +5.76±5.81 p=0.308 p<0.05 p=0.829 
TBUT (secs) -0.87±2.61 -1.28±2.03 p=0.383 p=0.094 p=0.265 
Bulbar Redness 
(CCLRU units) +0.64±0.58 +1.12±0.42 p<0.001 p<0.001 p<0.05 
Limbal Redness 
(CCLRU units) +0.70±0.31 +1.05±0.28 p<0.005 p<0.005 p=0.072 
Lid Redness 
(CCLRU units) +0.17±0.32 +0.07±0.35 p<0.05 p=0.157 p=0.487 
Lid Roughness 
(CCLRU units) +0.03±0.25 +0.00±0.40 p=0.459 p=1.00 p=0.506 
Type of corneal 
staining (CCLRU 
units) 
+0.53±0.41 +0.13±0.34 p=0.167 p=0.341 p=0.176 
Extent of corneal 
staining (CCLRU 
units) 
+0.49±0.65 +2.33±0.46 p=0.209 p<0.001 p<0.005 
Depth of corneal 
staining (CCLRU 
units) 
+0.37±0.47 +0.31±0.40 p=0.219 p<0.05 p=0.566 
 421 
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Figure 1: 25mm diameter impression tray holding Tresident material prior to insertion. 423 
 424 
 425 
 426 
Figure 2: Position of tray and Tresident during impression procedure. 427 
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